(p=0.001); 29% (p=0.001); 10% (p=0.06); 27% (p=0.009), respectively. Although only 26% of the patients have had an articular US, in 65% it led to a change in treatment. Positive answers to some questions, which were perhaps too complex, showed a discrete increase, less than 10%, conceivably due to the surprisingly high background of positive answers. Conclusions: As expected, the US image method was familiar to most but not its applicability in articular diseases. After the lecture there was an increase in understanding of the positive impact of US in rheumatic diseases, implying that short and focused lectures are a useful tool in educational programs for patients. Background: Fatigue, sleep disturbances and pain, are symptoms of primary Sjögren's syndrome (PSS). However, current clinical interventions predominantly focus on treating patients' dryness symptoms. Objectives: To explore the experience of fatigue, sleep disturbances and discomfort in people with PSS, to investigate the impact of these symptoms on patients' daily lives and to develop an intervention strategy to address them. Methods: Qualitative focus groups with open-ended questions allowed participants to explore ideas together and focus on issues they perceived as being important. PSS patients (n=10) and spouses (n=3) took part in three focus groups divided into six sessions which were facilitated by two clinician researchers using a topic guide. Discussion topics included; the symptoms, strategies used by patients used to manage their symptoms, possible future intervention components proposed from the literature and possible modes of delivering future interventions. The meetings were audio-recorded, transcribed verbatim and analysed using thematic analysis 1 . Results: Patient participants all experienced these symptoms. Symptom severity varied within individuals and flares occurred unpredictably. Fatigue, sleep disturbances and discomfort, all affected patients' lives and those around them and sometimes felt overwhelming. Discomfort symptoms included oral and ocular dryness, tingling, nausea and difficulties tolerating light and noise. The invisible nature of these features meant patients often struggled to meet others' expectations, which affected their mood and resulted in social withdrawal. Fatigue was a major barrier to engaging in work, productivity and leisure activities. Sleep disturbances further compounded the fatigue. Patients employed a range of strategies to self-manage their symptoms to varying degrees of success. Participants expressed a need for tailored support from health care professionals which included information provision, access to peer support and professional support to apply symptom management information. A three stepped model of care was proposed. The model includes different modes of delivering intervention content, including written information, education groups, peer support, digital self-management and one-to-one therapy. Intervention intensity increased with each step in the model.
Conclusions: Symptoms of fatigue, sleep disturbances and discomfort all impact on PSS patients' daily lives and individualised interventions are needed to support self-management. Care needs to be tailored as different patients require variable levels of support. A stepped model of future symptom management delivery is proposed. Numbers are n (%),
Conclusions:
The majority of JIA patients and controls participated in organized or unorganized PA. Fun was the most reported facilitator in patients, followed by becoming fit and having less pain. Pain was the dominant PA barrier in patients, while time was the most frequently reported barrier in controls. Some patients experienced disease activity as a barrier. Nearly all the patients (97%) participated regularly in PE, but 1 /4 needed some modifications. These results are reassuring, and highlight the importance of enjoyment for participation in PA. Background: Recently, the effectiveness of monitoring disease activity in rheumatoid arthritis (RA) through patient reported outcome (PRO) based telehealth follow-up was tested in a randomized controlled trail, TeRA (1). The TeRA study evaluated the effectiveness of the tele-health follow-up but did not study how patients grasp this new form of disease control. Many studies on tele-medicine focus on the over-all patient satisfaction with tele-medicine follow-up, but gives limited insight into what drives patient satisfaction (2). Objectives: To explore the experiences of a PRO based tele-health follow-up from the perspective of patients with RA with a special attention on experiences of taking a more active role and assuming more responsibility in the disease control. Methods: The qualitative research strategy was Interpretive Description (3). From October 2015 to January 2016 we conducted individual semi-structured interviews
